Blood Cancer and the Heart: Light Chain Cardiomyopathy in Refractory Multiple Myeloma.

Case Rep Cardiol · 2022 · PMC9356901 · PMID 35942233

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Daratumumab, a monoclonal antibody against the CD38 protein expressed on the clonal plasma cells, was associated with a shorter time to first hematologic and deep response as well as a highly significant improvement in cardiac and renal response in the ANDROMEDA trial either alone or in combination with CyBorD [ 10 – 12 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.